Hypertension in anaesthesia.
D000316:Adrenergic alpha-Agonists / Q000009:adverse effects / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000758:Anesthesia / Q000009:adverse effects*; D000777:Anesthetics / Q000009:adverse effects; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use; D004347:Drug Interactions; D004496:Education, Continuing; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy / Q000209:etiology*; D011184:Postoperative Period; D011292:Premedication; D011300:Preoperative Care; D011943:Receptors, Adrenergic, beta / Q000502:physiology; D013565:Sympatholytics / Q000009:adverse effects / Q000627:therapeutic use; D014655:Vascular Resistance; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use
D000316:Adrenergic alpha-Agonists; D000319:Adrenergic beta-Antagonists; D000777:Anesthetics; D002121:Calcium Channel Blockers; D004232:Diuretics; D011943:Receptors, Adrenergic, beta; D013565:Sympatholytics; D014665:Vasodilator Agents